Rocaglamide is the first cyclopenta[b]benzofuran analogue (flavagline), extracted from Aglaia elliptifolia in 1982 by King and colleagues based on its antileukemic activity. Like other flavaglines, rocaglamide exhibits potent insecticidal, antifungal, anti-inflammatory and anticancer activities. References: Luan Z, He Y, He F, Chen Z. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation. Mol Med Rep. 2015 Jan;11(1):203-11. doi: 10.3892/mmr.2014.2718. Epub 2014 Oct 21. PubMed PMID: 25333816; PubMed Central PMCID: PMC4237083.

纯度：≥98%

CAS：84573-16-0